LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission

The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

LSPN LIVE 2021: an ‘unmissable opportunity’

28 September 2021 Over the past year, the life sciences sector has proved to be of vital importance in the fight against COVID-19. Now more than ever, it is imperative that IP professionals are best positioned to protect and leverage innovation in this fast-paced industry.

Americas

LSPN Live: ‘Unimpressive’ Arthrex remedy fuels uncertainty

7 October 2021 The unpredictable nature of the US legal landscape has arguably kept IP practitioners on tenterhooks over the past decade.

Europe

Oxford University startup ordered to pay royalties

5 January 2023 ‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.